The 11th annual Harrington Prize for Innovation in Medicine was awarded to Dr. Arlene Sharpe, a professor at Kolokotrones University and chair of the department of immunology at Harvard Medical
The 10 winning images from the inaugural Bio-Art competition hosted by the Federation of American Societies for Experimental Biology (FASEB) were announced last week. Here are my favorites:
A mouse study led by Washington University School of Medicine in St. Louis suggests that combining SGLT2 inhibitors a newer class of diabetes medications that lowers blood sugar with older diabetes drugs may help to slow the progression of diabetic kidney disease.
Progression of diabetic kidney disease may be slowed with drug combinations – Washington University School of Medicine in St. Louis wustl.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wustl.edu Daily Mail and Mail on Sunday newspapers.
Humphreys
Benjamin D. Humphreys, MD, PhD, director of the Division of Nephrology at Washington University School of Medicine in St. Louis, has been named vice president of the American Society for Clinical Investigation (ASCI), a medical honor society that advances research by physician-scientists.
Humphreys, the Joseph Friedman Professor of Renal Diseases in Medicine, will serve as the society’s president during the 2023-24 term, making him at that point the university’s fourth faculty member to lead the 114-year-old organization.
Humphreys is internationally recognized for his clinical skills and his research on kidney fibrosis, stem cells and regenerative medicine.
Earlier this year, Humphreys also was invited to join the board of scientific counselors for the National Institute of Diabetes and Digestive and Kidney Diseases, of the National Institutes of Health (NIH). In this role, Humphreys will serve on a panel that helps evaluate research projects. See more information